Poxel S.A. POXEL.PA Stock
Poxel S.A. Price Chart
Poxel S.A. POXEL.PA Financial and Trading Overview
| Poxel S.A. stock price | 0.65 EUR |
| Previous Close | 0.67 EUR |
| Open | 0.69 EUR |
| Bid | 0 EUR x 0 |
| Ask | 0 EUR x 0 |
| Day's Range | 0.68 - 0.69 EUR |
| 52 Week Range | 0.59 - 2.82 EUR |
| Volume | 87.8K EUR |
| Avg. Volume | 107.7K EUR |
| Market Cap | 22.34M EUR |
| Beta (5Y Monthly) | 1.362835 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.08 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.6 EUR |
POXEL.PA Valuation Measures
| Enterprise Value | 54.11M EUR |
| Trailing P/E | N/A |
| Forward P/E | -0.56583333 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 33.146584 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 80.283 |
| Enterprise Value/EBITDA | -2.483 |
Trading Information
Poxel S.A. Stock Price History
| Beta (5Y Monthly) | 1.362835 |
| 52-Week Change | -58.73% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.82 EUR |
| 52 Week Low | 0.59 EUR |
| 50-Day Moving Average | 0.66 EUR |
| 200-Day Moving Average | 1.08 EUR |
POXEL.PA Share Statistics
| Avg. Volume (3 month) | 107.7K EUR |
| Avg. Daily Volume (10-Days) | 76.48K EUR |
| Shares Outstanding | 32.9M |
| Float | 22.64M |
| Short Ratio | N/A |
| % Held by Insiders | 9.61% |
| % Held by Institutions | 15.67% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3247.77% |
| Gross Margin | 0.29% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.53% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 674K EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | 380.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -21795000 EUR |
| Net Income Avi to Common (ttm) | -31398000 EUR |
| Diluted EPS (ttm) | -1.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.06M EUR |
| Total Cash Per Share (mrq) | 0.41 EUR |
| Total Debt (mrq) | 45.79M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.604 |
| Book Value Per Share (mrq) | -0.606 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21813000 EUR |
| Levered Free Cash Flow (ttm) | -15412375 EUR |
Profile of Poxel S.A.
| Country | France |
| State | N/A |
| City | Lyon |
| Address | Immeuble Le Sunway |
| ZIP | 69007 |
| Phone | 33 4 37 37 20 10 |
| Website | https://www.poxelpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 37 |
Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.
Q&A For Poxel S.A. Stock
What is a current POXEL.PA stock price?
Poxel S.A. POXEL.PA stock price today per share is 0.65 EUR.
How to purchase Poxel S.A. stock?
You can buy POXEL.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Poxel S.A.?
The stock symbol or ticker of Poxel S.A. is POXEL.PA.
Which industry does the Poxel S.A. company belong to?
The Poxel S.A. industry is Biotechnology.
How many shares does Poxel S.A. have in circulation?
The max supply of Poxel S.A. shares is 38.6M.
What is Poxel S.A. Price to Earnings Ratio (PE Ratio)?
Poxel S.A. PE Ratio is now.
What was Poxel S.A. earnings per share over the trailing 12 months (TTM)?
Poxel S.A. EPS is -1.08 EUR over the trailing 12 months.
Which sector does the Poxel S.A. company belong to?
The Poxel S.A. sector is Healthcare.
Poxel S.A. POXEL.PA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| CAC Small CS90 | 11739.13 EUR 12832.46 USD |
-0.74
|
— — | — — | — — | — - | — — |
| CAC Mid & Small MS190 | 14267.59 EUR 15596.4 USD |
-0.38
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}